As part of ASCEND2.0’s ongoing efforts to deepen partnerships with Principal Investigators and their institutions, John Chavez, Director of Program Engagement, recently visited two leading researchers whose work is pushing the boundaries of science in innovative and impactful ways.

At the University of Idaho, Chavez met with Dr. Ching-An Peng, who is pioneering a novel method for isolating plant-derived extracellular vesicles (EVs). Leveraging biodegradable chitin particles and intein-mediated splicing, Dr. Peng’s technique preserves the structural integrity and function of EVs—an advancement that could unlock new possibilities in drug delivery, cancer therapy, agriculture, and beyond. ASCEND2.0 is proud to support Dr. Peng as he advances this cutting-edge research and continues to explore real-world applications for his discoveries.

Learn more: Dr. Ching-An Peng Selected for ASCEND2.0 Cohort

Chavez also traveled to the University of Nevada, Reno to meet with Dr. Ruben Dagda, whose lab is exploring the role of mitochondrial function in neurodegenerative diseases, including Parkinson’s. Dr. Dagda’s research focuses on cellular pathways that protect mitochondrial health—offering potential for new therapeutic approaches that could slow disease progression and protect neurons. The visit provided an opportunity to discuss future collaboration and how ASCEND2.0 can continue to support his promising work.

Learn more: Dr. Ruben Dagda Selected for ASCEND2.0 Cohort

These visits reflect ASCEND2.0’s commitment to building strong relationships with researchers who are advancing bold, solution-driven science. Stay tuned as we continue to spotlight the groundbreaking work of our cohort members and explore new ways to elevate their research and impact.